X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-07-18 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $24.16 | -603 | 157,568 | 0% | -$14,566 | |||||
| M | 2024-07-11 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $23.39 | -736 | 108,158 | -1% | -$17,214 | |||||
| M | 2024-07-11 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.32 | -767 | 317,716 | 0% | -$17,888 | |||||
| M | 2024-07-11 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.48 | -780 | 60,903 | -1% | -$17,536 | |||||
| M | 2024-07-11 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $22.77 | -1,581 | 124,388 | -1% | -$35,992 | |||||
2024-09-16 | BLFS | Biolife Solutions Inc | Richardson Garrie | Chief Revenue Officer | S - Sale | $25.12 | -3,070 | 114,773 | -3% | -$77,118 | ||||||
| D | 2024-09-16 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $153.42 | -8,625 | 531,002 | -2% | -$1,323,210 | |||||
2024-09-11 | LIVN | Livanova Plc | Bianchi Francesco | Dir | S - Sale | $46.58 | -1,500 | 8,772 | -15% | -$69,870 | ||||||
| AM | 2024-08-28 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO, 10% | S - Sale | $28.34 | -10,881 | 50,313 | -18% | -$308,389 | |||||
| D | 2024-09-03 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $159.60 | -2,960 | 20,843 | -12% | -$472,404 | |||||
| M | 2024-08-28 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $47.43 | -10,705 | 84,573 | -11% | -$507,745 | |||||
| M | 2024-08-28 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $47.43 | -13,531 | 127,249 | -10% | -$641,783 | |||||
| M | 2024-08-28 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $47.43 | -10,705 | 112,040 | -9% | -$507,745 | |||||
| M | 2024-08-28 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $47.43 | -115,004 | 741,186 | -13% | -$5,454,707 | |||||
| M | 2024-08-28 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO, 10% | S - Sale | $28.34 | -10,780 | 83,791 | -11% | -$305,540 | |||||
| M | 2024-08-27 | SLNO | Soleno Therapeutics Inc | Vivo Opportunity, LLC | 10% | S - Sale | $48.01 | -1,025,000 | 6,291,851 | -14% | -$49,210,750 | |||||
| D | 2024-08-27 | TMDX | Transmedics Group, Inc. | Corcoran Nicholas | See Remarks | S - Sale+OE | $176.02 | -10,000 | 21,105 | -32% | -$1,760,200 | |||||
| DM | 2024-08-21 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $173.24 | -45,000 | 531,002 | -8% | -$7,795,600 | |||||
| M | 2024-08-19 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $1.88 | +1,254 | 2,794,068 | 0% | +$2,358 | |||||
2024-08-15 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $1.90 | +8,095 | 2,792,814 | 0% | +$15,350 | ||||||
| M | 2024-08-16 | STRR | Star Equity Holdings, Inc. | Coleman Richard Kenneth Jr. | CEO | P - Purchase | $5.20 | +3,000 | 39,067 | +8% | +$15,600 | |||||
| D | 2024-08-15 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $169.73 | -8,625 | 531,002 | -2% | -$1,463,919 | |||||
2024-08-15 | ECOR | Electrocore, Inc. | Errico Thomas J. | Dir | P - Purchase | $6.12 | +5,000 | 233,818 | +2% | +$30,595 | ||||||
2024-08-16 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.05 | -2,746 | 91,027 | -3% | -$2,883 | ||||||
| E | 2024-08-15 | POCI | Precision Optics Corporation, Inc. | Lawande Mahesh | COO | P - Purchase | $5.79 | +1,726 | 1,726 | New | +$9,994 | |||||
| E | 2024-08-15 | POCI | Precision Optics Corporation, Inc. | Coll Wayne M | CFO | P - Purchase | $5.79 | +4,317 | 4,317 | New | +$24,995 | |||||
| E | 2024-08-15 | POCI | Precision Optics Corporation, Inc. | Forkey Joseph Norman | CEO | P - Purchase | $5.79 | +1,725 | 122,572 | +1% | +$9,988 | |||||
2024-08-15 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $0.84 | -5,308 | 919,266 | -1% | -$4,459 | ||||||
2024-08-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $0.84 | -1,293 | 239,397 | -1% | -$1,086 | ||||||
2024-08-15 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $0.84 | -3,011 | 230,295 | -1% | -$2,529 | ||||||
2024-08-15 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $0.84 | -3,971 | 314,988 | -1% | -$3,336 | ||||||
2024-08-13 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $0.95 | +1,000 | 147,793 | +1% | +$950 | ||||||
| DM | 2024-06-05 | TMDX | Transmedics Group, Inc. | Ranganath Anil P. | See remarks | S - Sale+OE | $149.81 | -4,992 | 8,893 | -36% | -$747,838 | |||||
2024-08-08 | TMDX | Transmedics Group, Inc. | Tobin James R | Dir | S - Sale | $159.33 | -20,000 | 175,071 | -10% | -$3,186,536 | ||||||
| M | 2024-08-06 | ZYXI | Zynex Inc | Lucsok Anna | COO | S - Sale | $8.02 | -24,875 | 16,980 | -59% | -$199,410 | |||||
| D | 2024-08-06 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale+OE | $149.96 | -6,750 | 732 | -90% | -$1,012,230 | |||||
| M | 2024-08-05 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $45.60 | -10,974 | 95,278 | -10% | -$500,398 | |||||
| M | 2024-08-05 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $45.60 | -14,983 | 140,780 | -10% | -$683,202 | |||||
| M | 2024-08-05 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $45.60 | -11,009 | 122,745 | -8% | -$501,994 | |||||
| M | 2024-08-05 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $45.60 | -127,344 | 856,190 | -13% | -$5,806,696 | |||||
| D | 2024-08-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $156.77 | -2,958 | 20,843 | -12% | -$463,727 | |||||
| M | 2024-07-30 | VANI | Vivani Medical, Inc. | Dwyer Donald | Chief Business Officer | P - Purchase | $1.24 | +9,000 | 47,500 | +23% | +$11,120 | |||||
2023-11-22 | VANI | Vivani Medical, Inc. | Dwyer Donald | Chief Business Officer | P - Purchase | $0.96 | +2,000 | 38,500 | +5% | +$1,920 | ||||||
| D | 2024-07-31 | ITGR | Integer Holdings Corp | Hobby Jean M. | Dir | S - Sale+OE | $119.66 | -11,960 | 2,280 | -84% | -$1,431,132 | |||||
2024-07-31 | ITGR | Integer Holdings Corp | Maxwell Martin C | Dir | S - Sale | $118.88 | -4,700 | 20,656 | -19% | -$558,724 | ||||||
2024-07-30 | ITGR | Integer Holdings Corp | Harris John A | EVP, Global Ops, Manufactur | S - Sale | $123.80 | -3,400 | 1,522 | -69% | -$420,920 | ||||||
2024-07-29 | ZYXI | Zynex Inc | Disbrow Joshua R. | Dir | P - Purchase | $8.32 | +7,000 | 72,000 | +11% | +$58,233 | ||||||
2024-07-30 | ZYXI | Zynex Inc | Moorhead Daniel J | CFO | S - Sale | $8.24 | -15,000 | 122,247 | -11% | -$123,600 | ||||||
2024-07-24 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $4.02 | -723 | 240,690 | 0% | -$2,906 | ||||||
| D | 2024-07-15 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $145.17 | -8,625 | 531,002 | -2% | -$1,252,051 | |||||
2024-07-01 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $41.54 | -2,170 | 21,252 | -9% | -$90,136 | ||||||
2024-07-01 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $41.54 | -7,190 | 55,763 | -11% | -$298,654 | ||||||
2024-07-01 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $41.54 | -2,170 | 48,754 | -4% | -$90,136 | ||||||
2024-07-01 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $41.54 | -19,256 | 133,534 | -13% | -$799,844 | ||||||
2024-07-01 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $21.03 | -3,000 | 61,683 | -5% | -$63,090 | ||||||
| D | 2024-07-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $151.40 | -2,958 | 20,843 | -12% | -$447,853 | |||||
2024-06-28 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $1.75 | +1,000 | 146,793 | +1% | +$1,750 | ||||||
2024-06-18 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $0.71 | +1,619 | 145,793 | +1% | +$1,149 | ||||||
2024-06-14 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $20.18 | -10,000 | 108,894 | -8% | -$201,800 | ||||||
| D | 2024-06-14 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $141.85 | -8,625 | 531,002 | -2% | -$1,223,473 | |||||
| D | 2024-06-14 | CNMD | Conmed Corp | Peters Stanley W III | Pres AS, AET | S - Sale+OE | $71.82 | -4,000 | 63 | -98% | -$287,280 | |||||
2024-06-13 | ECOR | Electrocore, Inc. | Gandolfo John P | Dir | P - Purchase | $6.43 | +1,000 | 50,704 | +2% | +$6,430 | ||||||
2024-06-14 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $1.86 | +7,000 | 2,791,719 | 0% | +$13,017 | ||||||
2024-06-12 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $4.78 | -10,569 | 233,306 | -4% | -$50,520 | ||||||
2024-06-10 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $0.64 | +3,000 | 144,174 | +2% | +$1,920 | ||||||
| D | 2024-06-07 | MDT | Medtronic Plc | Martha Geoffrey | COB, CEO | S - Sale+OE | $83.77 | -19,113 | 143,348 | -12% | -$1,601,001 | |||||
2024-06-05 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale | $138.08 | -1,193 | 732 | -62% | -$164,729 | ||||||
2024-06-04 | ITGR | Integer Holdings Corp | Harris John A | EVP, Global Ops, Manufactur | S - Sale | $120.44 | -1,521 | 4,922 | -24% | -$183,182 | ||||||
| D | 2024-06-05 | ECOR | Electrocore, Inc. | Goldberger Daniel S | CEO | P - Purchase | $6.43 | +38,505 | 249,565 | +18% | +$247,587 | |||||
| D | 2024-06-03 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $135.93 | -2,060 | 21,299 | -9% | -$280,016 | |||||
| D | 2024-06-03 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $133.10 | -2,960 | 20,843 | -12% | -$393,986 | |||||
| D | 2024-06-03 | LIVN | Livanova Plc | Moore Daniel Jeffrey | Dir | S - Sale+OE | $60.11 | -56,623 | 27,534 | -67% | -$3,403,694 | |||||
2024-05-31 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $1.96 | +1,000 | 2,784,719 | 0% | +$1,958 | ||||||
| D | 2024-06-03 | OM | Outset Medical, Inc. | Grossman D Keith | Dir | S - Sale+OE | $3.78 | -38,117 | 79,221 | -32% | -$144,234 | |||||
2024-05-29 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $21.78 | -408 | 158,171 | 0% | -$8,886 | ||||||
2024-05-29 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $21.78 | -345 | 64,683 | -1% | -$7,514 | ||||||
2024-05-29 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $21.78 | -517 | 318,483 | 0% | -$11,260 | ||||||
2024-05-29 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $21.78 | -574 | 125,969 | 0% | -$12,502 | ||||||
2024-05-29 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $21.78 | -345 | 118,894 | 0% | -$7,514 | ||||||
| D | 2024-05-29 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $141.40 | -20,000 | 21,299 | -48% | -$2,828,025 | |||||
2024-05-29 | TMDX | Transmedics Group, Inc. | Weill David | Dir | S - Sale | $141.65 | -1,193 | 10,732 | -10% | -$168,988 | ||||||
| M | 2024-05-28 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $1.90 | +9,026 | 2,774,719 | 0% | +$17,186 | |||||
| D | 2024-05-24 | ITGR | Integer Holdings Corp | Hinrichs James F. | Dir | S - Sale+OE | $122.44 | -9,603 | 7,424 | -56% | -$1,175,772 | |||||
2024-05-17 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $22.18 | -73 | 119,239 | 0% | -$1,619 | ||||||
2024-05-17 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.18 | -98 | 319,000 | 0% | -$2,174 | ||||||
2024-05-17 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $22.18 | -115 | 126,543 | 0% | -$2,551 | ||||||
2024-05-17 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $22.18 | -85 | 158,579 | 0% | -$1,885 | ||||||
2024-05-17 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.18 | -57 | 65,028 | 0% | -$1,264 | ||||||
2024-05-16 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $3.53 | -3,918 | 318,959 | -1% | -$13,831 | ||||||
2024-05-16 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $3.53 | -1,097 | 241,413 | 0% | -$3,872 | ||||||
2024-05-16 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $3.53 | -2,972 | 243,875 | -1% | -$10,491 | ||||||
2024-05-16 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $3.53 | -5,237 | 924,574 | -1% | -$18,487 | ||||||
2024-05-15 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $22.67 | -10,000 | 119,312 | -8% | -$226,700 | ||||||
| D | 2024-05-15 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $135.32 | -8,625 | 531,002 | -2% | -$1,167,147 | |||||
2024-05-16 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $0.88 | -2,753 | 93,773 | -3% | -$2,423 | ||||||
| M | 2024-05-14 | CUTR | Cutera Inc | Karavitis Michael | EVP, CTO | S - Sale | $2.60 | -63,603 | 0 | -100% | -$165,438 | |||||
2024-05-10 | TMDX | Transmedics Group, Inc. | Weill David | Dir | S - Sale | $129.82 | -2,500 | 11,193 | -18% | -$324,550 | ||||||
| A | 2024-05-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale | $108.54 | -63,260 | 20,843 | -75% | -$6,866,104 | |||||
2024-05-10 | ITGR | Integer Holdings Corp | Khales Payman | Pres, C, V | S - Sale | $113.84 | -8,712 | 10,431 | -46% | -$991,739 | ||||||
2024-05-13 | CNMD | Conmed Corp | Bronson David M | Dir | P - Purchase | $72.09 | +1,350 | 16,460 | +9% | +$97,322 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |